These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9411549)

  • 21. [Seroepidemiological profile of hepatitis B infection in staff at hemodialysis units of Goiânia-Goiás, Central Brazil].
    Rodriguez Lopes CL; Bringel Martins RM; Araújo Teles S; Silva SA; Maggi PS; Tachibana Yoshida CF
    Rev Soc Bras Med Trop; 2001; 34(6):543-8. PubMed ID: 11813061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prevalence of the serological markers of the hepatitis B virus in a nonhospital population].
    Masqué J; Cano P; Ripoll J; García RM
    Aten Primaria; 1993 Jun; 12(2):119-20. PubMed ID: 8329545
    [No Abstract]   [Full Text] [Related]  

  • 23. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of hepatitis B markers.
    Lodenyo H
    Trop Gastroenterol; 2000; 21(1):12-3. PubMed ID: 10835953
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serologic diagnosis and follow-up of hepatitis B].
    Frei PC; Grob PJ
    Soz Praventivmed; 1998; 43 Suppl 1():S10-3, S84-7. PubMed ID: 9833256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serology of HBV and its clinical implications among Nigerian subjects.
    Ola SO; Olaleye DO; Olubuyide IO
    Trop Gastroenterol; 2008; 29(3):163-6. PubMed ID: 19115609
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.
    Iwai K; Tashima M; Itoh M; Okazaki T; Yamamoto K; Ohno H; Marusawa H; Ueda Y; Nakamura T; Chiba T; Uchiyama T
    Bone Marrow Transplant; 2000 Jan; 25(1):105-8. PubMed ID: 10654023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
    Uhm JE; Kim K; Lim TK; Park BB; Park S; Hong YS; Lee SC; Hwang IG; Koh KC; Lee MH; Ahn JS; Kim WS; Jung CW; Kang WK
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):463-8. PubMed ID: 17382252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
    Challine D; Chevaliez S; Pawlotsky JM
    Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Delta infection in patients with chronic liver diseases].
    Rumiantsev ON; Ivlev AS; Vasil'ev AP
    Voen Med Zh; 1992 Jul; (7):41-3. PubMed ID: 1455778
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevalence of serum markers of hepatitis B virus in patients hospitalized with pelvic inflammatory disease].
    Mozas J; Miranda C; Jimena P; Herruzo AJ
    Med Clin (Barc); 1993 Feb; 100(8):319. PubMed ID: 8464280
    [No Abstract]   [Full Text] [Related]  

  • 33. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra].
    Santos A; Carvalho A; Tomaz J; Rodrigues V; Coxinho L; Bento D; Sá R; Porto A
    Acta Med Port; 2000; 13(4):167-71. PubMed ID: 11155483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H
    Transfus Med; 2009 Aug; 19(4):189-94. PubMed ID: 19708860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
    Daw MA; Siala IM; Warfalli MM; Muftah MI
    Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level hepatitis B viraemia.
    Howell DR; Eglin R
    Transfus Med; 2005 Feb; 15(1):63; author reply 65-6. PubMed ID: 15713132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis A, B, and C in an occupational center for the mentally handicapped].
    Arnedo A; Latorre MD; Pac MR; Safont L; Guillén F; Aguinaga I
    Enferm Infecc Microbiol Clin; 1998 Oct; 16(8):370-3. PubMed ID: 9835153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.